No actionable signal. Director-level cashless exercise-and-sell transactions at 0.0005% of market cap are routine and non-informative. Monitor for C-suite open-market sales or purchases at materially larger scale (>$10M) before reading any directional signal.
GILD drugs
GILD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 28 $145.68entry
- T+1 · 3mo ago +0.45%α +0.75% · $146.34
- T+5 · 2mo ago +3.65%α +3.54% · $151.00
- T+20 · 7w ago +4.48%α +4.22% · $152.21
- T+55 · todayOpen
- T+60 · in 6d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two GILD directors sold a combined $926K in open-market sales over a one-week window. Director Anthony Welters executed a multi-leg transaction on Aug 26, exercising derivative options at $0 and $60.67-$61.35 strike prices, then immediately selling the resulting shares at ~$148.82 for $685K in proceeds. Director Jeffrey Bluestone sold 1.7K shares at $145.73 for $242K on Aug 20. The total open-market sale value of $926K represents approximately 0.0005% of GILD's $183.6B market cap, a trivial amount that falls well below the 0.1% materiality threshold. These are routine cashless exercise-and-sell transactions by directors, not informed selling.
Key Financial Metrics
Key Facts
- Two directors sold a combined $926K in open-market sales over 7 days
- Total sales represent ~0.0005% of GILD's $183.6B market cap
- Director Welters exercised 28,282 derivative shares at $0-$61.35, then sold 18,000 shares at ~$148.82
- Director Bluestone sold 1,700 shares at $145.73 for $242K
- All sales are cashless exercise-and-sell transactions, not conviction sells
Financial Impact
$926K in open-market sales, 0.0005% of market cap, immaterial
Risk Factors
- None, transaction value is trivial relative to market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GILD-1787872138733 |
Track record
30 reports on GILD
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
- Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
- Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers